Asofarma Central America & Caribbean in strategic alliance with other international companies has within its range of products, the following licenses:
- AMGEN, (USA). For VECTIBIX® (Panitumumab).
- AMGEN, (USA). For MIMPARA® (Cinacalcet).
- AMGEN, (USA). For N-PLATE® (Romiplostin).
- AMGEN, (USA). For NEULASTIM® (Pegfilgastrim).
- ASTELLAS, (Japan). For XTANDI® (Enzalutamide).
- CELGENE (USA). For REVLIMID® (Lenalidomide).
- CELGENE (USA). For VIDAZA® (Azacitidine).
- CELGENE (USA). For POMALYST® (Pomalidomide).
- CELGENE (USA). For ABRAXANE® (albumin protein bound paclitaxel).
- CLINIGEN (United Kingdom). For CARDIOXANE® (Dexrazoxane).
- MEIJI SEIKA PHARMA (Japan). For OLTER® / SUPRAHYAL® (Sodium Hyaluronate).
- TOLMAR (USA). For ELIGARD® (Leuprolide acetate).